TY - JOUR
T1 - Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure
AU - Rengo, Giuseppe
AU - Leosco, Dario
AU - Zincarelli, Carmela
AU - Marchese, Massimo
AU - Corbi, Graziamaria
AU - Liccardo, Daniela
AU - Filippelli, Amelia
AU - Ferrara, Nicola
AU - Lisanti, Michael P.
AU - Koch, Walter J.
AU - Lymperopoulos, Anastasios
PY - 2010/6
Y1 - 2010/6
N2 - Exercise training has been reported to exert beneficial effects on cardiac function and to reduce morbidity and mortality of chronic heart failure (HF). Augmented sympathetic nervous system (SNS) activity, leading to elevated circulating catecholamine (CA) levels, is a hallmark of chronic HF that significantly aggravates this disease. Exercise training has been shown to also reduce SNS overactivity in HF, but the underlying molecular mechanism(s) remain unidentified. We recently reported that adrenal G protein-coupled receptor kinase-2 (GRK2), an enzyme that regulates the sympathoinhibitory α2-adrenoceptors (α2-ARs) present in the CA-producing adrenal medulla, is upregulated in HF, contributing to the chronically elevated CA levels and SNS activity of the disease. In the present study, we tested whether exercise training can affect the adrenal GRK2-α2-AR-CA production system in the context of HF. For this purpose, a 10-wk-long exercise training regimen of adult male Sprague-Dawley rats starting at 4 wk postmyocardial infarction (post-MI) was employed, and examination at the end of this treatment period revealed significant amelioration of β-AR-stimulated contractility in response to exercise training, accompanied by cardiac GRK2 reduction and restoration of circulating plasma CA levels. Importantly, adrenal GRK2 expression (72 ± 5% reduction vs. post-MI untrained) and α2-AR number were also restored after exercise training in post-MI animals. These results suggest that exercise training restores the adrenal GRK2-α2-AR-CA production axis, and this might be part of the mechanism whereby this therapeutic modality normalizes sympathetic overdrive and impedes worsening of the failing heart.
AB - Exercise training has been reported to exert beneficial effects on cardiac function and to reduce morbidity and mortality of chronic heart failure (HF). Augmented sympathetic nervous system (SNS) activity, leading to elevated circulating catecholamine (CA) levels, is a hallmark of chronic HF that significantly aggravates this disease. Exercise training has been shown to also reduce SNS overactivity in HF, but the underlying molecular mechanism(s) remain unidentified. We recently reported that adrenal G protein-coupled receptor kinase-2 (GRK2), an enzyme that regulates the sympathoinhibitory α2-adrenoceptors (α2-ARs) present in the CA-producing adrenal medulla, is upregulated in HF, contributing to the chronically elevated CA levels and SNS activity of the disease. In the present study, we tested whether exercise training can affect the adrenal GRK2-α2-AR-CA production system in the context of HF. For this purpose, a 10-wk-long exercise training regimen of adult male Sprague-Dawley rats starting at 4 wk postmyocardial infarction (post-MI) was employed, and examination at the end of this treatment period revealed significant amelioration of β-AR-stimulated contractility in response to exercise training, accompanied by cardiac GRK2 reduction and restoration of circulating plasma CA levels. Importantly, adrenal GRK2 expression (72 ± 5% reduction vs. post-MI untrained) and α2-AR number were also restored after exercise training in post-MI animals. These results suggest that exercise training restores the adrenal GRK2-α2-AR-CA production axis, and this might be part of the mechanism whereby this therapeutic modality normalizes sympathetic overdrive and impedes worsening of the failing heart.
KW - Adrenal G protein-coupled receptor kinase-2
KW - Catecholamines
KW - Sympathetic overactivity
UR - http://www.scopus.com/inward/record.url?scp=77952635752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952635752&partnerID=8YFLogxK
U2 - 10.1152/ajpheart.00702.2009
DO - 10.1152/ajpheart.00702.2009
M3 - Article
C2 - 20304818
AN - SCOPUS:77952635752
SN - 0363-6119
VL - 298
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 6
ER -